Since 1996, three world-renowned Harvard Medical School-affiliated institutions—Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Massachusetts General Hospital—have worked together to provide the best possible treatment of adult cancers. Through this collaboration known as Dana-Farber/Partners CancerCare, Dana-Farber/Brigham and Women’s Cancer Center and Massachusetts General Hospital Cancer Center, provide comprehensive, multidisciplinary care to more than 12,000 new cancer patients.

Multidisciplinary Treatment
Adult care is organized into 12 multidisciplinary treatment programs: breast cancer, endocrine cancer, gastrointestinal cancer, genitourinary cancer, gynecological cancer, head and neck cancer, hematologic malignancies, hematology, melanoma, neurologic cancer, sarcoma, and thoracic oncology. Through each treatment program, patients have access to specialized cancer physicians, surgeons, radiation oncologists, nurses, social workers, and other staff. These clinicians work with patients and referring physicians to develop care plans. All aspects of diagnosis and treatment are available, from genetic and molecular testing to a full array of support services, including individual and group counseling.

Clinical Research
Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Massachusetts General Hospital are leaders in cancer research and rank as the top three independent recipients of National Institutes of Health research funding in the United States. Their collaboration brings together each institution's diverse capabilities in research to help speed the transition of new discoveries into effective patient therapies. Together, Dana-Farber/Brigham and Women’s Cancer Center and Massachusetts General Hospital Cancer Center activate more than 10 new cancer trials each month and now has more than 350 active clinical trials underway. Currently, more than 2,200 patients a year are enrolled in clinical research trials that offer them access to promising new therapies and, at the same time, provide valuable information that may lead to better treatments for all cancer patients.

Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Massachusetts General Hospital are each members of Dana-Farber/Harvard Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center.